.Net Invest Report Research 
socalTECH
OCTOBER 7, 2010
A new report released today by Next 10 , a nonprofit, nonpartisan public policy group, says that Southern California--and California, as a whole--leads the green innovation, cleantech venture capital, and energy market. The report was compiled by research firm Colaborative Economics.
Xconomy
NOVEMBER 7, 2016
Back in 2013, Google reported that 90 percent of multiple device owners switch between screens to complete tasks, using an average of three different combinations every day. Meanwhile, biometrics has stepped out of the realm of sci-fi and into the mainstream, playing an important role in the fight against cybercrime.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Startup Professionals Musings
FEBRUARY 10, 2014
In fact, BusinessWeek reports that roughly 40 percent of the S&P 500 chief executives have MBAs in any given year. With a little research I found a few notable names in relatively recent businesses, although each of these actually started with some big-company experience: Fred Smith, chairman and founder, Federal Express.
Tech Coast Venture Network
MARCH 9, 2011
Last year, venture capitalists and angels who co-invested with them placed $7 billion into seed and early-stage deals, an 11 percent increase from 2009, according to the most recent PricewaterhouseCoopers/National Venture Capital Association MoneyTree report. The group invested $8.7 million in 2010. million in 2010. TCVN News'
Startup Professionals Musings
JANUARY 4, 2013
In fact, BusinessWeek reports that roughly 40 percent of the S&P 500 chief executives have MBAs in any given year. With a little research I found a few notable names in recent businesses, although each of these actually started with some big-company experience: Fred Smith, chairman and founder, Federal Express.
Xconomy
AUGUST 26, 2016
—Cambridge-based startup Amylyx Pharmaceuticals raised a $5 million Series A round from Morningside Venture, the ALS Investment Fund, and former Genzyme CEO Henri Termeer to develop a drug meant to stop the death of nerve cells in patients with amyotrophic lateral sclerosis. Alex Lash contributed to this report.
Tech Zulu Event
FEBRUARY 3, 2012
Even investors and experienced founders are caught in the same net as recently educated graduates looking to build companies. or purely invest in established U.S. nationals, making it difficult for investing founders to reach requirements, as well an application checklist with no set amount. Attracting business investment.
Expert insights. Personalized for you.
165 
Let's personalize your content